Parallax Volatility Advisers
NERV icon

Parallax Volatility Advisers’s Minerva Neurosciences NERV Stock Holding History

Parallax Volatility Advisers’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-536
Closed -$26K – 3561
2017
Q4 		$26K Buy
+536
New +$26.6K ﹤0.01% 3565
2017
Q3 		– Sell
-682
Closed -$48K – 2854
2017
Q2 		$48K Buy
+682
New +$44.1K ﹤0.01% 1805

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Parallax Volatility Advisers's NERV Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Minerva Neurosciences (NERV) in Q1 2018, closing a stake of 536 shares — an estimated $26K sold.

Parallax Volatility Advisers first reported a position in NERV in Q2 2017 and held it in 2 quarters. The position peaked at $48K in Q2 2017. 67 funds tracked by Wall St. Rank hold NERV as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Minerva Neurosciences position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 536 Minerva Neurosciences shares in Q1 2018, an estimated $26K.
  • Parallax Volatility Advisers first reported a position in Minerva Neurosciences in Q2 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Minerva Neurosciences position peaked at $48K in Q2 2017.
  • 67 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.